3rd September 2021 | Pharma Updates

Granules India will make and market DRDO’s 2-DG

The company has recently received a license from DRDO for the same.

MGC Pharma will now import Covid treatment in India

The company has received a license to import its Covid treatment in our country.

Sun Pharma's subsidiary sells its complete shareholding to Shinshin Pharma

Sun Pharma’s Japan unit has sold complete shareholding to Shinshin Pharma for a total amount of JPY 353983400.

DRL, Natco roll out the anti-cancer drug in Canada

Both drugmakers have introduced generic drugs for patients with multiple myeloma and myelodysplastic syndrome in Canada.

Aspen is in dialogue with J & J to market anti-Covid drug

The drugmaker is also looking forward to expanding its vaccine manufacturing from 30 mn doses to 45 mn doses by February of next year.

Sai Life Sciences receives an award from CII

The company’s API unit has received an award for its energy management.

DCGI gives authority to Biological E for the Covid vaccine trial

Biological E’s vaccine for kids clinical trials will be conducted across 10 locations in India.